AVXL Hedge Fund Ownership (Q1 2026)

Anavex Life Sciences Corp (AVXL)

187 + Investors. Track Smart Money conviction in AVXL. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — AVXL

Based on 190 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added AVXL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

190 hedge funds hold AVXL right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

〰️

Stable — ownership unchanged year-over-year

fund count last 6Q

The number of hedge funds holding AVXL is almost the same as a year ago (+6 funds, +3% change). No significant rush to buy or sell — institutional backing is holding steady.

🟡

Slight buying edge — 58% buying

114 buying83 selling

Last quarter: 114 funds bought or added vs 83 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~37 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 23 → 29 → 32 → 37. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

52% of holders stayed for 2+ years

■ 52% conviction (2yr+) ■ 28% medium ■ 20% new

98 out of 190 hedge funds have held AVXL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +5%, value -36%

Value

-36%

+5%

Last quarter: funds added +5% more shares while total portfolio value only changed -36%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📈

Growing discovery — still being found

38 → 23 → 29 → 32 → 37 new funds/Q

New funds entering each quarter: 23 → 29 → 32 → 37. A growing number of institutions are discovering AVXL each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 59% veterans vs 26% newcomers

■ 59% veterans ■ 15% 1-2yr ■ 26% new

Entry-cohort mix of 197 holders: 116 (59%) are 2+ year veterans, 30 entered 1–2 years ago, and 51 (26%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 63% AUM from top-100 funds

63% from top-100 AUM funds

46 of 186 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in AVXL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

3.6

out of 10

Low Exit Risk

Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	187	186	0.54%
13F Shares	43M	41M	4.56%
Total Value	$132M	$209M	-36.74%
New Positions	36	32	+4
Increased Positions	74	66	+8
Closed Positions	35	30	+5
Reduced Positions	45	52	-7
Total Calls	8	10	-20.0%
Total Puts	3	7	-57.14%
PUT/CALL Ratio	0.38	0.7	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

187

186

0.54%

13F Shares

43M

41M

4.56%

Total Value

$132M

$209M

-36.74%

New Positions

Increased Positions

Closed Positions

Reduced Positions

-7

Total Calls

-20.0%

Total Puts

-57.14%

PUT/CALL Ratio

0.38

0.7

Bullish

Institutional Holders (2026 Q2)

187 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AVXL. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 AVXL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Pvg Asset Management Corp	0.49%	327,344	$848K
2	Great Point Partners LLC	0.26%	521,300	$1.4M
3	EntryPoint Capital, LLC	0.08%	28,154	$119K
4	Graetz Wealth LLC	0.03%	14,044	$36K
5	Summit Financial, LLC	0.03%	909,430	$2.4M
6	Abel Hall, LLC	0.03%	56,832	$147K
7	Innovative Asset Advisors Group, LLC	0.02%	17,350	$45K
8	LexAurum Advisors, LLC	0.02%	65,050	$168K
9	Sheets Smith Wealth Management	0.02%	71,259	$185K
10	180 Wealth Advisors, LLC	0.02%	71,030	$184K
11	Axq Capital, LP	0.01%	40,748	$106K
12	Yukon Wealth Management, Inc.	0.01%	13,992	$36K
13	Apella Capital, LLC	0.01%	227,995	$618K
14	Hamilton Point Investment Advisors, LLC	0.01%	20,300	$53K
15	Bnc Wealth Management, LLC	0.01%	11,250	$29K
16	Private Advisor Group, LLC	0.01%	504,000	$1.3M
17	Two Sigma Investments, LP	0.01%	3,046,538	$7.9M
18	Bridgeway Capital Management, LLC	0.01%	123,000	$319K
19	Foster Victor Wealth Advisors, LLC	0.01%	39,925	$97K
20	Strategic Family Wealth Counselors, L.L.C.	0.00%	8,045	$21K
21	Millstone Evans Group, LLC	0.00%	3,000	$8K
22	Federated Hermes, INC.	0.00%	1,071,809	$2.8M
23	Strategic Family Wealth Counselors, L.L.C.	0.00%	6,000	$16K
24	Delta Asset Management LLC/Tn	0.00%	16,000	$41K
25	Massar Capital Management, LP	0.00%	12,729	$33K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Anavex Life Sciences Corp (AVXL)

What does the Smart Money Trend signal show for AVXL?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added AVXL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for AVXL?

Slight buying edge — 58% buying: Last quarter: 114 funds bought or added vs 83 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for AVXL holders?

Elite ownership — 63% AUM from top-100 funds: 46 of 186 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in AVXL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held AVXL?

52% of holders stayed for 2+ years: 98 out of 190 hedge funds have held AVXL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Anavex Life Sciences Corp (AVXL)

Smart Money Signals — AVXL

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Stable — ownership unchanged year-over-year

Slight buying edge — 58% buying

Steady new buyers — ~37 new funds per quarter

52% of holders stayed for 2+ years

Buying through price weakness — shares +5%, value -36%

Growing discovery — still being found

Veteran-anchored — 59% veterans vs 26% newcomers

Elite ownership — 63% AUM from top-100 funds

Institutional Sentiment Summary — AVXL

Hedge Fund Ownership: AVXL

Market Analysis: AVXL

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: AVXL

Hedge Fund Positioning: AVXL

Statistics: AVXL

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Anavex Life Sciences Corp (AVXL)

Welcome to 13Foresight!